Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Edoardo Mannucci MD

Edoardo Mannucci MD

Associate Professor of Endocrinology, University of Florence, Italy; Head, Unit of Diabetes and Metabolic Diseases, Careggi Teaching Hospital, Florence, Italy

Dr. Edoardo Mannucci was born in Prato, Italy, in 1965. He graduated as Medical Doctor in 1990 and obtained his specialty in Endocrinology in 1995, at the University of Florence Medical School. He worked as a contract researcher at the Metabolic Section of the Endocrinology Unit of the Careggi hospital of the University of Florence, and then as Consultant Diabetologist at the Diabetes Section of the Geriatric Unit of the same hospital.

Since 2009, he is the Director of the Diabetology Unit of Careggi teaching hospital in Florence. He has been member of the Scientific Board of the Italian Society of Diabetology and of the National Boards of the Italian Obesity Society and of the Italian Society for the Study of Eating Disorders.

He has authored more than 250 papers on International peer-reviewed journals. His research activities have included several different fields related to diabetes, such as eating behavior and psychological aspects of diabetes and obesity, physiology of the incretin axis, and erectile dysfunction and male hypogonadism in metabolic diseases. More recently, his research has been focused on pharmacological treatments for type 2 diabetes.


Dr. Mannucci has received speaking and/or consulting fees from Astra Zeneca, Boehringer Ingelheim and Merck.

Recent Contributions to PracticeUpdate:

  1. SGLT2 Inhibitors and Cancer Outcomes